Efficacy and safety of a T‐type calcium channel blocker in patients with neuropathic pain: A proof‐of‐concept, randomized, double‐blind and controlled trial von Kerckhove, N., Pereira, B., Soriot‐Thomas, S., Alchaar, H., Deleens, R., Hieng, V.S., Serra, E., Lanteri‐Minet, M., Arcagni, P., Picard, P., Lefebvre‐Kuntz, D., Maindet, C., Mick, G., Balp, L., Lucas, C., Creach, C., Letellier, M., Martinez, V., Navez, M., Delbrouck, D., Kuhn, E., Piquet, E., Bozzolo, E., Brosse, C., Lietar, B., Marcaillou, F., Hamdani, A., Leroux‐Bromberg, N., Perier, Y., Vergne‐Salle, P., Gov, C., Delage, N., Gillet, D., Romettino, S., Richard, D., Mallet, C., Bernard, L., Lambert, C., Dubray, C., Duale, C., Eschalier, A.

Volltext